JAMP CETIRIZINE TABLETS
Identification of Jamp Cetirizine Tablets
| No description |
Google image searchProduct monograph
Active ingredient
cetirizine hydrochloride, 20 MG
DIN: 02517353
Dosage form(s): TABLET
Route(s) of administration: ORAL
Schedule: Prescription
Company: JAMP PHARMA CORPORATION
Date: 11-MAY-2022
ATC:
- R06 — ANTIHISTAMINES FOR SYSTEMIC USE (ATC, ATC/DDD, )
- R06A — ANTIHISTAMINES FOR SYSTEMIC USE (ATC, ATC/DDD)
- R06AE — Piperazine derivatives (ATC, ATC/DDD)
- R06AE07 — CETIRIZINE (ATC/DDD)
Reference brand drug: Reactine
Pharmaceutical standard: USP
